June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.
April 25, 2019: stigma and viral load among African-American women; U.S. HIV incidence sans racial disparities; the care continuum is failing young MSM; a moment of reckoning regarding HIV among U.S. youth.
The impact of stigma on cognitive performance; risk factor dissonance among young black MSM; pregnancy and the HIV care continuum; new data on pediatric raltegravir use.
Bridgette Brawner, Ph.D., APRN, was recently honored for her research on heterosexually active black teens with mental illness -- a group that's under-represented in HIV prevention campaigns.
High HIV prevalence among black MSM on PrEP; substance use reduction lessens depressive symptoms; correlations between pain symptoms and age; the impact of seroconversion and antiretroviral therapy on risk behaviors.
Tonya Taylor, Ph.D., a specialist in sexual health, walks us through the changes and challenges that can affect women of color who are aging with HIV or become positive later in life.
It's been 20 years to the day since Magic Johnson disclosed his HIV status, instantly changing the face of the epidemic. But today, we're starving for a straight, HIV-positive celebrity who can be this generation's role model. We're certain he's out ...